NEXIUMI.V. (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the NEXIUM drug offered from AstraZeneca Pharmaceuticals LP. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
NON-PROPRIETARY NAME: | Esomeprazole sodium |
SUBSTANCE NAME: | ESOMEPRAZOLE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-05-03 |
END MARKETING DATE: | 0000-00-00 |
NEXIUM I.V. HUMAN PRESCRIPTION DRUG Details:
Item Description | NEXIUM I.V. from AstraZeneca Pharmaceuticals LP |
LABELER NAME: | AstraZeneca Pharmaceuticals LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/5mL) |
START MARKETING DATE: | 2005-05-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0186-6020_d8c73701-98e2-4ad4-9103-7cdbad12a852 |
PRODUCT NDC: | 0186-6020 |
APPLICATION NUMBER: | NDA021689 |
Other ESOMEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers: